Processing timeline
1
days
Filed
21 July 2026
Decision Due
31 Aug 2026
Est decision date: 22 Aug 2026. Based on 46 decided Professional & Business Services notifications.
Acquirer(s)
L'Oréal India Private Limited
Target(s) or Vendor(s)
Onesto Labs Private Limited CIN - U74999DL2018PTC340749
Other parties
L'Oréal S.A. SIREN - 632 012 100
L'Oréal S.A., through its subsidiary L'Oréal India Private Limited, proposes to acquire 65.22% of the share capital of Onesto Labs Private Limited (Innovist). This share sale involves two key players in the beauty and personal care products industry, with L'Oréal selling major brands and Innovist offering brands like Bare Anatomy.
L'Oréal S.A. and its subsidiaries ( L'Oréal ), through its wholly-owned subsidiary L'Oréal India Private Limited, proposes to acquire 65.22% of the share capital of Onesto Labs Private Limited ( Innovist ). L'Oréal conducts research, development, manufacturing, marketing, distribution and sale of beauty and personal care products. In Australia, L'Oréal sells haircare, skincare, makeup and fragrances wholesale through pharmacies, supermarkets and retailers, as well as through their own branded retail stores YSL Beauty Boutiques, Aesop and Kiehl’s. L'Oréal supplies key brands in Australia such as L'Oréal, Garnier, Maybelline, Lancôme, Yves Saint Laurent, Vichy, La Roche Posay, Kérastase, Aesop and Kiehl’s. Innovist manufactures and sells beauty and personal care products. Innovist sells hair care, skincare and sun care products under the brand names Bare Anatomy, Chemist at Play, SunScoop and Vinci. In Australia, Innovist sells its Bare Anatomy and Chemist at Play products directly to consumers.
The ACCC has prepared a questionnaire on the Acquisition. Submissions or information in response to the questionnaire should be provided by 29 July 2026 via email to mergers@accc.gov.au with the title L'Oréal – Innovist .